04.02.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing

Discover how T-cell culture media supplemented with key cytokines can maintain full functionality and support robust expansion for up to 12 days at room temperature.

Learn about a next-generation transfection system that requires 50% less plasmid, decreases transfection reagent consumption, and yields higher AAV productivity to reduce cost per dose.

A milliliter-scale approach to IVT optimization reveals how controlled feeding, precise pH management, and real-time monitoring can boost mRNA yield and streamline scale-up to larger bioreactor volumes.

Pharma faces mounting complexity and tighter margins, demanding agile, future-ready production. Check out how smart manufacturing enables faster adaptation and continuous therapy availability.

Explore insights into an AAV manufacturing platform designed to achieve short timelines and cost-effective scalability for producing clinical trial and commercial material in bioreactors up to 2000 L.

As CGT developers gain knowledge about their processes, single-use technologies (SUT) manufacturers can better address the sector's unique autologous needs by adapting to smaller volume production.

Cleanroom systems are purposely designed to simplify the implementation of the aseptic manufacturing space that the industry needs to meet future sterile injectable capacity demand.

Investigate how CAR-T cells treat hematopoietic malignancies as well as the correlation between flow cytometry and qPCR in monitoring CAR-T cell therapy, which validates their combined use for accurate assessment.

Watch how this novel approach to VLP manufacturing can overcome common scalability and consistency issues, enabling high yields and potent gene editing in a single day.